Merosin or laminin alpha 2 chain deficiency (Q103659): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
A distrofia muscular congênita com deficiência de merosina pertence a um grupo de doenças neuromusculares com início no nascimento ou na infância, caracterizadas por hipotonia, fraqueza muscular e perda de massa muscular. A distrofia muscular congênita com deficiência de merosina representa 30-40% das distrofias musculares congênitas. | |||
| description / en | description / en | ||
Merosin-deficient congenital muscular dystrophy belongs to a group of neuromuscular disorders with onset at birth or infancy characterised by hypotonia, muscle weakness and muscle wasting. Merosin-deficient congenital muscular dystrophy represents 30-40% of congenital muscular dystrophies. | |||
Revision as of 09:24, 17 August 2026
Merosin-deficient congenital muscular dystrophy belongs to a group of neuromuscular disorders with onset at birth or infancy characterised by hypotonia, muscle weakness and muscle wasting. Merosin-deficient congenital muscular dystrophy represents 30-40% of congenital muscular dystrophies.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1693850954 |
||
| English | Merosin or laminin alpha 2 chain deficiency |
Merosin-deficient congenital muscular dystrophy belongs to a group of neuromuscular disorders with onset at birth or infancy characterised by hypotonia, muscle weakness and muscle wasting. Merosin-deficient congenital muscular dystrophy represents 30-40% of congenital muscular dystrophies. |
